Fixed-dose Versus Concentration-controlled Mycophenolate Mofetil for the Treatment of Active Lupus Nephritis

PHASE4TerminatedINTERVENTIONAL
Enrollment

2

Participants

Timeline

Start Date

August 20, 2019

Primary Completion Date

January 30, 2020

Study Completion Date

January 30, 2020

Conditions
Lupus Nephritis
Interventions
DRUG

Mycophenolate Mofetil

"Description Each capsule contains Mycophenolate mofetil 250 mg. Presentation / Packing Cap 250 mg (white to off white powder, light blue/peach hard gelatin, imprinting with MMF on cap and 250 on body) x 10 x 10's.~Storage Store below 30 degree Celcius."

Trial Locations (1)

10330

King Chulalongkorn Memorial Hospital, Bangkok

Sponsors
All Listed Sponsors
collaborator

Berlin Pharmaceutical Industry

UNKNOWN

lead

Chulalongkorn University

OTHER